Neurology
1 drug is in development for Muscle Weakness.
- Companies
- 1
- Clinical trials
- 8
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Muscle Weakness pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| anito-cel | Arcellx, Inc. (ACLX) |
About this indication
Muscle Weakness context
Neurology·MeSH: Muscle Weakness (D018908)
Also known as: Muscle Weaknesses, Muscular Weaknesses, Weakness, Muscular
Frequently asked questions
How many drugs are in development for Muscle Weakness?
BioSniper tracks 1 drug in development for Muscle Weakness across 1 company.
How many clinical trials target Muscle Weakness?
There are 8 clinical trials targeting Muscle Weakness tracked by BioSniper.